Clinical Trial Update: Pharmacogenetics in Primary Care Psychotropics [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on pharmacogenetics in primary care psychotropics sponsored by the University of Arizona, studying major depressive disorder, obse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-compulsive Disorder

Snippet

Sponsor: University of Arizona | Conditions: Depression, Obsessive-Compulsive Disorder | Phase 3 | Status: UNKNOWN